Further work is required to investigate the functional role of Rab35 in ovarian cancer, but this gene may have use as a biomarker of AR function in ovarian cancer, thus being able to predict those patients who are likely to respond to antiandrogen therapy. The gene discussed is RAB35; the disease is ovarian cancer.